To evaluate the feasibility, safety, and patient-reported outcomes following day-case robotic adrenalectomy performed under an ERAS protocol, emphasizing the protocol's role in enhancing recovery.
Postoperative satisfaction assessed using the EVAN-G questionnaire.
Complication rates and specific safety outcomes were also recorded.
Interpretation:
The study suggests that day-case robotic adrenalectomy is feasible and safe under an ERAS protocol, potentially improving patient outcomes and influencing future surgical practices.
Limitations:
Small sample size of thirteen patients.
Single-centre study may limit generalizability and introduce potential biases.
Conclusion:
Day-case robotic adrenalectomy following an ERAS protocol is a promising approach that warrants further investigation, particularly in multicentre trials.
